newsfilter
← Latest News
Business Wire·

Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC

Hologic, Inc. (NASDAQ:HOLX) today announced that it has entered into an agreement with the Centers for Disease Control and Prevention (CDC) to develop analyte specific reagents (ASRs) — the "active ingredients" of